ArticleFrontiers in child and adolescent psychiatry2026
Predicting schizophrenia spectrum disorders in pediatric outpatients: a prospective validation of the child psychosis-risk screening system.
Article in Frontiers in child and adolescent psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study validated the prognostic ability of the Child Psychosis-risk Screening System (CPSS), an algorithm derived from the widely used Child Behavior Checklist (CBCL), and benchmarked its performance against a comprehensive machine learning model. Methods: This prospective cohort study enrolled 491 pediatric psychiatric outpatients aged 6-18 years who visited clinics for developmental, psychosomatic, or psychiatric disorders. Baseline assessments (Visit 1) included the CBCL and extensive clinical data. Participants were followed-up for up to 5 years (n = 350; Visits 2+), including annual assessments for schizophrenia spectrum disorders (SSD). The predictive accuracy of the CPSS risk score was evaluated using receiver operating characteristic analysis and compared with that of a post-hoc machine learning benchmark model (Light Gradient Boosting Machine) incorporating 150 baseline variables. Results: The CPSS risk score demonstrated good predictive performance for final SSD status (area under the curve [AUC] = 0.906), significantly exceeding its discriminative ability for SSD at Visit 1 (AUC = 0.841). This discrepancy indicates that the CPSS sensitively captures prodromal vulnerabilities that do not yet meet diagnostic criteria. Although the complex Light Gradient Boosting Machine model achieved a marginally higher AUC (0.959), the CPSS yielded comparably robust accuracy using only eight CBCL subscales. Variable-importance analysis further showed that the CPSS risk score was a stronger predictor than the CBCL "Thought Problems" scale, a traditional marker of psychosis risk. Conclusion: The CPSS is a parsimonious and effective screening tool that translates behavioral observations into objective risk stratification. Its use in primary care settings could streamline referral pathways and facilitate timely early intervention for children at high risk of psychosis who present with ambiguous somatic or behavioral symptoms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.